Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$217,733,740
-$66,283,173 QoQ
Shares Held
1,331,542
-18.4% QoQ
Ownership
0.614%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 87.54406545193467.ToString("F0")%
Shared 0.ToString("F0")%
None 12.455934548065326.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. INSM ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in INSM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $217,733,740 | 1,331,542 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $284,016,913 | 1,631,906 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $138,772,496 | 963,631 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $105,047,121 | 1,043,791 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $80,841,151 | 1,059,656 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $93,298,231 | 1,351,365 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $96,432,343 | 1,320,991 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $55,127,868 | 822,804 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $25,491,423 | 939,603 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $47,561,802 | 1,534,747 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $17,137,828 | 678,726 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $8,977,709 | 425,484 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,426,548 | 787,481 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $19,519,258 | 976,940 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,311,927 | 664,435 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,504,018 | 836,918 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $19,898,998 | 846,766 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $15,150,039 | 556,169 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $24,619,985 | 893,972 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $23,614,710 | 829,751 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $19,144,000 | 562,067 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $20,077,131 | 603,098 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $13,883,739 | 431,977 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $14,221,296 | 516,387 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,281,370 | 516,617 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||